ABSTRACT
F
amilial Mediterranean Fever (FMF) is the most common form of periodic fever syndromes, which is caused by mutations in the MEFV gene. It is characterized by sporadic unpredictable attacks of fever, arthritis and serositis 1 . The prevalence is particularly higher in certain ethnic groups within the Mediterranean basin, such as Sephardic Jews, Armenians, Turks, Arabs and Druze 2 . The diagnosis is usually made on clinical basis and the genetic tests for MEFV gene are supportive.
Aside from symptoms and signs of episodic attacks of inflammation, FMF is a major cause of accumulation of amyloid A amyloidosis (AAA). AAA secondary to FMF can involve many different organs, but most frequently the kidneys, spleen, liver and gut. One of the earliest targets of AAA in FMF is the kidney, which can be manifested initially with isolated proteinuria and later with increased creatinine levels.
Cardiovascular system is an important target of AAA, with significant morbidity and mortality at advanced stages. FMF may cause pericarditis due to serositis and/or cardiac amyloidosis as a part of the systemic disease 3 . Recent studies investigated repolarization abnormalities using markers such as QT dispersion, transmural dispersion of repolarization and P-wave dispersion in FMF patients with and without AAA [4] [5] [6] . Peak to end interval of T wave is newermarker of cardiac repolarization abnormality, which has been suggested as a better predictor of sudden cardiac death or ventricular tachycardia 7 . We aimed to evaluate cardiac repolarization indices and their correlates in patients with FMF with and without AAA.
Materials and Methods

Study population
Patients who had been followed up between June 2004 and June 2014 in the outpatient clinic of Nephrology of Sisli Hamidiye Etfal Educational and Research Hospital and who were diagnosed with FMF according to Tel Hashomer criteria were included. Diagnosis of amyloidosis was confirmed by renal biopsy in all amyloidosis positive FMF patients. Past medical history and the medications of the patients were recorded. Exclusion criteria were history of congenital or acquired heart diseases, inflammatory attack within the previous month, drug ingestion that may have an effect on ECG, chronic diseases (such diabetes, hypertension, hypothyroidism, organ failure, etc.). Age and gender comparable healthy subjects were recruited as the control group. This is a cross-sectional study in design and variables were obtained between September 2014 and December 2014. The following clinical and laboratory variables were recorded and used for analysis: age, gender, body-mass index(BMI), serum glucose, urea, creatinine levels, electrolytes (Na, K), albumin, lipids, fibrinogen, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), urine analysis, daily proteinuria, blood pressure, electrocardiography (ECG) and echocardiography (ECHO) parameters.
BMI was calculated by dividing weight (kilograms) by height squared (meters). Plasma level of CRP was measured by nephelometric method and ESR was determined by the Westergreen method.
Procedure
All ECG recordings were obtained using the same 12-lead commercial device (Nihon Kohden, Cardiofax M, Tokyo, Japan) while the patients were resting in supine position for 10 minutes at a room temperature of [20] [21] [22] [23] o C between 09:00 and 14:00. The device was set at a 50 mm/s paper speed and 2mV/cm. All participants were asked to avoid smoking, intake of caffeinated, alcoholic beverages and other stimulants within 3 hours and strenuous exercise 24 hours prior to study.
QT intervals were corrected according to the Bazett's formula (QTc) and the difference between maximum and minimum QTc intervals in each electrocardiogram was calculated as QT dispersion (QTd). The Tpe interval was measured as the distance between the peak and the end of T wave in the precordial lead V5 (or in leads V4 and V6 if not measurable in V5), and was corrected according to heart rate ( Figures 1a and 1b show samples of QT and Tpe measurements). Tpe/QTc ratio was calculated from these measurements. Subjects with U waves on their ECGs were excluded from the study. All ECG measurements were performed by a single blinded observer.
Statistical analysis
SPSS 20.0 software (SPSS Inc, Chicago, USA) was used for statistical analysis. Parametric data were presented as mean ± SD. Normality test was performed to all variables. Student t-test was used for parametric variables and Mann Whitney U test was used for non-parametric distribution of variables. Spearman and Pearson tests were used for correlation analysis. Yates correction, chi-square test and Fisher's exact test were used for comparison of categorical data. One-way ANOVA with Tukey post-hoc analysis correction was used for intergroup analysis. Multivariate analyses were performed by logistic regression. P value < 0.05 was considered as significant.
The study was approved by local Ethics Committee, and informed consent was obtained from each participant.
Results
General characteristics
Clinical characteristics, laboratory and echocardiographic parameters and repolarization indices of the FMF patients and the controls are shown in Table 1 . There were 67 FMF patients and 30 healthy controls eligible to study. The mean disease duration was 9.1 ± 8.2 years and all FMF patients were receiving 1 to 1.5 mg/day colchicine, orally.
All of the general characteristics were similar between FMF patients and the controls, except for mildly lower diastolic blood pressure and higher proteinuria, LV ejection fraction and LV mass index in the FMF group. Notably, inflammatory markers (ferritin, CRP, ESR and fibrinogen) were also similar between the two groups (Tables 1 and  2 ). However, patients with amyloidosis had higher levels of proteinuria, LV mass index, ESR and fibrinogen when compared to patients without amyloidosis (Table 3) .
Cardiac repolarization
QT and QTc intervals were within the normal ranges and similar between the patients and controls (p > 0.05), whereas Tpe interval, Tpe/ QT ratio and Tpe/QTc ratio were significantly increased in patients with FMF as compared to the healthy controls (p < 0.001) ( Table 2 ). When repolarization indices were compared between FMF patients with and without amyloidosis, we found that QT and QTc intervals were within the normal ranges and similar between the two groups, whereas Tpe interval, Tpe/QT and Tpe/QTc ratios were higher in patients who had amyloidosis as compared to those without amyloidosis (Table 4 and Figure 3 ). Tpe interval, Tpe/QT and Tpe/QTc ratios still remained higher in FMF patients as compared to healthy controls, even after the patients with amyloidosis were excluded from the analysis.
Correlation analysis
Proteinuria and the presence of amyloidosis showed moderate correlations with Tpe interval, Tpe/QT and Tpe/QTc ratios, but not with QT or QTc intervals (Table 5 ). Tpe interval was weakly correlated with male gender, serum albumin, left atrial diameter, LVEDD and moderately with figure 2. Spearman correlation between levels of proteinuria and Tpe intervals. amyloidosis, proteinuria, LV mass index, posterior wall thickness, and LVESD (Table 6 and Figure 2 ). There were no correlations between Tpe and age, inflammatory markers, blood pressure and the other laboratory parameters (Table 6 ).
Discussion
Several rheumatic disorders, such as rheumatoid arthritis and systemic lupus erythematosus, have been shown be associated with cardiovascular morbidity and mortality, that cannot be attributed to traditional cardiovascular risk factors 8 . Major causes for these adverse cardiovascular effects are accelerated atherosclerosis, small vessel vasculitis within the heart, degeneration of the conduction system, and endocardium damage. Cardiac arrhyth mias and conduction disturbances are part of the consequences of cardiac involvement in rheumatic diseases 9 . Likewise, secondary amyloidosis can produce cardiac arrhythmias and conduction disturbances as a result of deposition of amyloid fibrils within the myocardium and possibly autonomic nervous system dysfunctions 10 . Nussinovitchetal published several studies regarding cardiac repolarization abnormalities in FMF patients. In their studies, FMF patients with and without amyloidosis had similar repolarization indices (QT interval, QTc interval and QT dispersion) to those of healthy controls 5, 11 . When colchicine resistant FMF patients were compared to healthy controls, they also revealed that cardiac repolarization indices were similar between the two groups 12 . Another study from Turkey with a similar design also found that there were not differences in ventricular repolarization indices between FMF patients and healthy controls 13 . Giese et al compared FMF patients without amyloidosis and Nussinovitch et al. compared FMF patients with amyloidosis to health controls to searched for supraventricular indices. Both of them found that P-wave duration and dispersions were comparable between FMF patients and healthy controls 14, 15 . Young FMF patients with relatively short disease duration were included in this study to investigate cardiac arrhythmogenicity basis before and early after the development of overt amyloidosis. The sample size was relatively larger than previous studies and all patients were under colchicine treatment. QT interval and QTc values of both FMF patients and healthy controls were within the normal rangesand comparable, like findings in the aforementioned studies. However, in contrast to some of the previous studies, all indices that reflect ventricular repolarization abnormalities were significantly higher in FMF patients than in healthy controls. When we separated patients with and without amyloidosis, we found that QTd was higher in amyloidosis negative FMF patients than in healthy controls. This value was even higher in amyloidosis positive than in amyloidosis negative FMF patients. LV mass indices and the levels of proteinuria were highest in amyloidosis positive FMF patients and lowest in healthy controls. Proteinuria and amyloidosis were factors showing the best correlation with QTd. Markers of inflammation were comparable between healthy controls and FMF patients and they were not correlated with QTd.
In a cross-sectional study by Akcay et al., QTd was found to be higher in FMF patients similar to our results 4 . Arslan et al. looked for atrial arrhythmogenicity in pediatric FMF patients, and unlike other studies theyfound that P wave dispersion was higher in FMF patients than in healthy controls 16 . Tpe interval is a relatively newer marker of ventricular arrhythmia and suggested to correspond to transmural dispersion of repolarization. Tpe/QT is constant at normal heart rates and has a mean value of 0.21 in healthy individuals 17 . Tpe and Tpe/QT were found to be associated with adverse outcomes in patients with myocardial infarction, Brugada syndrome, bradyarrhythmia, and hypertrophic cardiomyopathy 7, [18] [19] [20] . Tpe and Tpe/QT have not been studied previouslyto evaluate ventricular repolarization in FMF patients. In our study, Tpe, Tpe/QT and Tpe/QTc were significantly higher in FMF patients as compared to healthy controls. These parameters were even more increased in patients who developed amyloidosis than in patients without amyloidosis. In correlation analysis, these parameters showed similar results to QTd correlations. Proteinuria, amyloidosis and LV mass index were factors showing the best correlation with Tpe, Tpe/QT and Tpe/QTc. These findings suggest that there may be subclinical amyloid deposition within the myocardium before the development of detectable cardiac amyloidosis, and the presence of renal amyloidosis (or proteinuria) may be a sign of more advanced disease.
Our studyindicates that there may be subclinical arrhythmogenic potential in FMF patients, even before the development of overt amyloidosis. However, there is a lot of controversy in the literature regarding to whether there are repolarization abnormalities or tendency to arrhythmia in patients with FMF. The causes of this may include limitations of study designs, inter-observer and intra-observer variability in measuring intervals from ECG recordings, and using different ECG recorders. Another aspect of such studies is that they do not show whether the actual risk of ventricular arrhythmia is increased in FMF. In a prospective design, 24 to 72 hours of continuous ECG recordings in a large cohort of FMF patients and computer based measurements may provide with the actual prevalence of arrhythmia and its correlation to repolarization indices.
Conclusions
QTd, Tpe, Tpe/QT and Tpe/QTc were higher in FMF patients as compared to healthy controls, and these parameters were even more elevated in patients who developed amyloidosis. These parameters were moderately correlated with proteinuria, amyloidosis and LV mass index. Increased Tpe in FMF was shown in this study for the first time to our knowledge. The clinical significance of these findings has not been shown yet, but they suggest that arrhythmogenic potential may be increased in FMF patients. Data in the literature are not uniform and better study designs are needed to answer unresolved questions.
